Paper Details

  1. Home
  2. Paper Details

Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.

Author: CaiBinyu, CuiFuqiang, HuangFang, LiLiqiu, LiYabin, LiangXiaofeng, LiuMin, NieLi, PangXinghuo, QiuQian, RaoDelong, WangFuzhen, WangHuai, WuJiang, ZhangGuomin, ZhangWei

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A new type of 60 μg Hepatitis B vaccine was tested in a clinical trial to determine its immunogenicity and safety compared with other hepatitis B vaccines in a primary immune population.
Paper Details　
Original Abstract of the Article :
The widely recommended standard schedule of hepatitis B vaccine for adults is months 0, 1 and 6, which takes 6 months to complete. Rapid completion of one vaccination schedule is important to adults because of its low compliance with follow-up doses. A new type of 60 μg Hepatitis B vaccine, made by ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137542/

データ提供：米国国立医学図書館（NLM）

A New Era in Hepatitis B Vaccination: Faster Protection with 60µg Vaccine

Hepatitis B vaccination is a cornerstone of public health, preventing serious liver disease. This research focuses on a novel 60µg hepatitis B vaccine, exploring its potential to provide faster and more effective protection compared to traditional 20µg vaccines. The study aimed to evaluate the immunogenicity and safety of the 60µg vaccine in adults, highlighting its potential as a rapid immunization option.

Accelerating Hepatitis B Vaccination

The study found that the 60µg hepatitis B vaccine demonstrated superior immunogenicity compared to traditional 20µg vaccines, potentially enabling faster completion of the vaccination schedule. This finding has significant implications for improving vaccination rates and reducing the risk of hepatitis B infection.

Improving Vaccine Efficacy and Access

This research represents a significant advancement in hepatitis B vaccination, offering a faster and more effective immunization option. The availability of a 60µg vaccine could lead to improved vaccination coverage and reduced incidence of hepatitis B infection.

Dr.Camel's Conclusion

Think of a desert traveler venturing into a new and unknown land. A 60µg hepatitis B vaccine, like a sturdy camel, provides faster and more robust protection against the dangers of hepatitis B, allowing the traveler to confidently explore new horizons. This research highlights the potential of innovative vaccine strategies to enhance protection against infectious diseases.

Date :
  1. Date Completed 2017-10-02
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

27648684

DOI: Digital Object Identifier

PMC5137542

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.